Daniel A. Segal

Daniel A.
Segal is Vice President of Emerging Stem Cell Therapy for ThermoGenesis Corp.
He rejoined ThermoGenesis in February 2007 as Vice President of Sales & Marketing.
Prior to rejoining ThermoGenesis, Mr. Segal worked for GE Healthcare Cell Technologies in Business Development.
Prior to that, he held various positions for the ThermoGenesis over a seven and half year period, including Director of Sales & Marketing Blood Products and Director of Corporate Sales and V.P.
Sales/Marketing.
Mr. Segal's experience includes over 25 years in Blood Banking, Transfusion Medicine and Specialty Surgical Devices & Implants, where he held various positions of increasing responsibility in Sales & Marketing.
He graduated from Sonoma State College with a BA in Business Management.